-
About UsBeijing Northland Biotechnology Co., Ltd. is an innovative biopharmaceutical company specializing in the research, development, production, and sales of gene therapy drugs, recombinant protein drugs, and ophthalmic drugs. -
R&D and ProductsPrimarily dedicated to the research, development, and industrialization of novel bioengineered drugs in areas such as cardiovascular diseases, metabolic disorders, rare diseases, and ophthalmic diseases. -
Investor RelationsGuided by the principle of “Creating Value, Serving Health,” the company is committed to becoming an innovative biopharmaceutical enterprise, contributing to the advancement of China’s pharmaceutical industry and the well-being of humanity.
2009
February 18
The company is listed on the Over-the-Counter Share Transfer System for Non-Listed Joint-Stock Companies in the Zhongguancun Science Park of the Shenzhen Stock Exchange (“New Third Board”).
March 25
The NL003 project has received FDA approval from the U.S. for Phase I/II clinical trials for the treatment of diabetic peripheral neuropathy (BB IND 13,938) and for the treatment of myocardial infarction (BB IND 13,948).
May 6
The NL005 project, “Thymosin β4 Derivatives and Their Applications,” has been granted a Chinese invention patent.
August 24
Obtained recognition from Beijing’s science and technology research and development institutions.
December 24
Three new drug projects of the company have been approved as key projects under the “National Major New Drug Creation” science and technology special program of the 11th Five-Year Plan.
December 17
The company has been awarded the title of “100 Innovative Enterprises” by the Zhongguancun Science Park.
Share to:
Friendly Links: Baidu | NORTHLAND
Contact Information
Address: Room A406, Zhongguancun Biomedical Park, No. 5 Kaituo Road, Shangdi, Haidian District, Beijing
Follow Us
Northland is an innovative biopharmaceutical company specializing in the R&D, manufacturing and sales of gene therapy drugs, recombinant protein drugs and ophthalmic medications.
Web site
NL-BIO
NL003
NL005